ストックスクリーナーアプリを入手
297.71
0.52%
-1.57
アフターアワーズ：
297.71
前日終値:
$299.28
開ける：
$295.96
24時間の取引高:
138.01K
Relative Volume:
0.68
時価総額：
$8.03B
収益：
$2.58B
当期純損益:
$-778.69M
株価収益率:
-10.89
EPS:
-27.33
ネットキャッシュフロー:
$223.75M
1週間 パフォーマンス:
-4.81%
1か月 パフォーマンス:
-2.03%
6か月 パフォーマンス:
+12.69%
1年 パフォーマンス:
-17.04%
1日の値動き範囲:
$295.96
$300.59
1週間の範囲:
$293.94
$316.63
52週間の値動き範囲:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
名前
Bio Rad Laboratories Inc
セクター
電話
(510) 724-7000
住所
1000 ALFRED NOBEL DRIVE, HERCULES
BIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
297.71 | 8.07B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-04-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-12-07 | 開始されました | UBS | Buy |
| 2023-06-16 | 開始されました | Wells Fargo | Overweight |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-01-28 | 繰り返されました | Citigroup | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2018-10-17 | 開始されました | Goldman | Buy |
| 2018-09-20 | 開始されました | Morgan Stanley | Equal-Weight |
| 2018-02-16 | ダウングレード | CL King | Buy → Neutral |
| 2017-07-13 | 開始されました | Wells Fargo | Outperform |
| 2017-06-28 | アップグレード | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 開始されました | Deutsche Bank | Hold |
| 2016-10-13 | 開始されました | CL King | Buy |
| 2015-05-06 | 繰り返されました | Jefferies | Buy |
| 2009-12-18 | 開始されました | Maxim Group | Buy |
| 2009-11-06 | 開始されました | Jefferies & Co | Buy |
| 2009-07-17 | 開始されました | Soleil | Buy |
| 2007-09-26 | 開始されました | Banc of America Sec | Buy |
| 2007-02-23 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Bio Rad Laboratories Inc (BIO) 最新ニュース
Bank Watch: Is Bio Rad Laboratories Incs ROE strong enoughStock Surge & Weekly Top Gainers Trade List - baoquankhu1.vn
Incredible Growth of Cancer Monoclonal Antibodies Market - openPR.com
Cell Culture Media Market Covering Prime Factors - openPR.com
Biomarkers Market to Reach US$ 148.88B by 2032 | CAGR 11.9% | North - openPR.com
Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider - GlobeNewswire Inc.
Income Plays: Is XFLTPRA a good ESG investmentWeekly Trade Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
Sector Gamma AS Buys 4,998 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Performance Recap: Can Bio Rad Laboratories Inc generate free cash flowWeekly Market Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Rapid Food Safety Testing Growth Driven by SGS Leadership - Market.us
Thermal Cycler Market Market Set to Boom: Strategic Insights - openPR.com
Is Bio-Rad Laboratories (BIO) Starting To Look Attractive After Prolonged Share Price Weakness? - Sahm
Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth - Seeking Alpha
Cell Counting System Market Overview and Leading Players: - openPR.com
Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Proteomics Market Dynamics and Contributions by Thermo Fisher - openPR.com
Qiagen Explores Possible Sale After New Buyer Talks: Report - Sahm
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now - Yahoo Finance
Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com
United States Protein Labeling Market Growth (2025-2032): Key - openPR.com
Lab on Chip Market Set for Dynamic Development with Key Players - openPR.com
Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
AI Stocks: Is Bio Rad Laboratories Inc likely to announce a buybackNew Guidance & Long-Term Investment Growth Plans - baoquankhu1.vn
Trading Action: Can Bio Rad Laboratories Inc generate free cash flowJuly 2025 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Protein Chip Market to Reach US$ 7.6 Billion by 2032 at 15.9% CAGR; - openPR.com
Bio-Rad Laboratories Is Quietly Eating the Lab World – But Is BIO Stock Worth Your Cash? - AD HOC NEWS
Blood Screening Market Outlook 2026-2033: Technological - openPR.com
Microfluidics Market to Reach US$ 73.97 Billion by 2032 at 12.6% - openPR.com
Revenue Check: How correlated is Bio Rad Laboratories Inc to the S P5002025 Macro Impact & Verified Trade Idea Suggestions - baoquankhu1.vn
DNA/RNA Extraction Kit Market to Reach US$ 6.9 Billion by 2032 - openPR.com
SG Americas Securities LLC Buys 5,600 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Fund Flows: Can RF Acquisition Corp II Debt Equity Composite Units ride the EV waveMarket Trend Report & Expert Verified Movement Alerts - baoquankhu1.vn
DNA Extraction Kits Market Growth Outlook: Booming - openPR.com
Laboratory Equipment and Disposables Market is expected - openPR.com
Surprises Report: Will Bio Rad Laboratories Inc stock maintain growth story - Bộ Nội Vụ
Income Plays: What drives Bio Rad Laboratories Incs stock price2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
Why retail investors pile into Bio Rad Laboratories Inc stock2025 Winners & Losers & Fast Moving Trade Plans - Bộ Nội Vụ
Bio-FET Market to Witness 8.5% CAGR by 2033: Abbott - openPR.com
Entry Recap: Can Bio Rad Laboratories Inc Class stock surprise with quarterly resultsMarket Weekly Review & Weekly Top Gainers Trade List - Bộ Nội Vụ
Epigenetics Market Booming with Rapid Growth Through 2033 | F. - openPR.com
Will Bio Rad Laboratories Inc. stock recover faster than marketJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - ulpravda.ru
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed actionJuly 2025 PreEarnings & Consistent Growth Stock Picks - Улправда
Bio-Rad Laboratories (NYSE:BIO) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
(BIO) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Why Bio Rad Laboratories Inc. stock appeals to analystsLong Run Comfort Guide & quick comparison of popular models - Улправда
Protein engineering market is set for steady growth to reach US$ - openPR.com
What insider trading reveals about Bio Rad Laboratories Inc. stockGap Up & Safe Entry Trade Reports - Улправда
Why Bio Rad Laboratories Inc. stock is trending among retail tradersOptions Play & Daily Momentum Trading Reports - Улправда
What analyst consensus says on Bio Rad Laboratories Inc. stockJuly 2025 Final Week & Consistent Growth Equity Picks - Улправда
Is Bio Rad Laboratories Inc. stock resilient to inflationMarket Growth Report & Consistent Growth Stock Picks - Улправда
Bio Rad Laboratories Inc (BIO) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
0.96%
大文字化:
|
ボリューム (24 時間):